Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Dexcom Inc (DXCM)

Dexcom Inc (DXCM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,838,976
  • Shares Outstanding, K 390,772
  • Annual Sales, $ 4,033 M
  • Annual Income, $ 576,200 K
  • EBIT $ 600 M
  • EBITDA $ 818 M
  • 60-Month Beta 1.28
  • Price/Sales 7.28
  • Price/Cash Flow 33.42
  • Price/Book 13.95

Options Overview Details

View History
  • Implied Volatility 44.34% ( +4.46%)
  • Historical Volatility 44.70%
  • IV Percentile 56%
  • IV Rank 33.60%
  • IV High 78.36% on 10/09/24
  • IV Low 27.12% on 05/16/24
  • Put/Call Vol Ratio 1.10
  • Today's Volume 2,586
  • Volume Avg (30-Day) 5,073
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 140,017
  • Open Int (30-Day) 126,533

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.33
  • Number of Estimates 11
  • High Estimate 0.43
  • Low Estimate 0.28
  • Prior Year 0.32
  • Growth Rate Est. (year over year) +3.13%

Price Performance

See More
Period Period Low Period High Performance
1-Month
68.30 +8.05%
on 03/13/25
91.87 -19.67%
on 02/25/25
-14.98 (-16.87%)
since 02/21/25
3-Month
68.30 +8.05%
on 03/13/25
93.25 -20.86%
on 02/18/25
-6.24 (-7.80%)
since 12/20/24
52-Week
62.34 +18.38%
on 07/26/24
142.00 -48.03%
on 03/26/24
-59.61 (-44.68%)
since 03/21/24

Most Recent Stories

More News
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

RMD : 219.70 (-0.64%)
MASI : 165.82 (-2.17%)
PODD : 268.32 (+1.10%)
IRTC : 104.49 (+0.14%)
DXCM : 73.80 (-1.74%)
Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next

Equity markets started 2025 pretty well, but things haven't been so rosy in the past couple of months. The tech-heavy Nasdaq Composite index is down by 8% since the beginning of the year as I write this....

COMP : 9.39 (+3.30%)
VRTX : 503.20 (-1.37%)
DXCM : 73.80 (-1.74%)
Is DexCom Stock Underperforming the Dow?

DexCom significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s long term prospects.

DXCM : 73.80 (-1.74%)
STE : 220.42 (-2.24%)
$DOWI : 41,985.35 (+0.08%)
DXCM : 73.80 (-1.74%)
Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD)

RMD : 219.70 (-0.64%)
MASI : 165.82 (-2.17%)
IRTC : 104.49 (+0.14%)
PODD : 268.32 (+1.10%)
DXCM : 73.80 (-1.74%)
Stocks Fall on Growth Fears and Tech Stock Plunge

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -2.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -3.81%. March E-mini...

MSTR : 304.00 (+0.64%)
GOOGL : 163.99 (+0.73%)
AAPL : 218.27 (+1.95%)
TAP : 58.89 (-0.17%)
HRL : 29.98 (+1.01%)
ADI : 204.40 (-0.73%)
ADM : 46.10 (-0.90%)
COIN : 189.86 (-0.27%)
TSLA : 248.71 (+5.27%)
CTSH : 76.42 (-1.02%)
^BTCUSD : 84,810.16 (+0.72%)
CME : 263.35 (-1.20%)
Stocks Drop on Tariff Anxiety and Economic Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -1.94%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -3.18%. March E-mini S&P futures...

MSTR : 304.00 (+0.64%)
GOOGL : 163.99 (+0.73%)
AAPL : 218.27 (+1.95%)
TAP : 58.89 (-0.17%)
HRL : 29.98 (+1.01%)
KHC : 29.52 (-0.64%)
ADM : 46.10 (-0.90%)
COIN : 189.86 (-0.27%)
TSLA : 248.71 (+5.27%)
CTSH : 76.42 (-1.02%)
^BTCUSD : 84,810.16 (+0.72%)
CME : 263.35 (-1.20%)
Stocks Set to Open Sharply Lower as U.S. Recession Talk Lingers, Inflation Data Awaited

March S&P 500 E-Mini futures (ESH25) are down -0.90%, and March Nasdaq 100 E-Mini futures (NQH25) are down -1.04% this morning, while Treasury yields also fell, as concerns about the health of the U.S....

MSTR : 304.00 (+0.64%)
MARA : 12.38 (-0.96%)
AVGO : 191.66 (+0.59%)
DG : 83.66 (+2.44%)
ULTA : 350.57 (+2.84%)
ORCL : 152.23 (-0.32%)
DKS : 195.45 (+2.14%)
DASH : 190.62 (-1.20%)
ESH25 : 5,617.80s (-0.79%)
WBA : 11.10 (-0.18%)
GAP : 20.02 (-2.25%)
ADBE : 387.26 (-0.60%)
3 Growth Stocks to Buy and Hold Forever

The best way to grow your wealth and better prepare yourself for retirement is to accumulate shares of solid growth stocks to own for the long term. As these companies steadily grow their revenue and profits,...

SKX : 56.08 (-0.51%)
SYK : 371.11 (-0.83%)
DXCM : 73.80 (-1.74%)
Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

Reflecting On Patient Monitoring Stocks’ Q4 Earnings: DexCom (NASDAQ:DXCM)

RMD : 219.70 (-0.64%)
MASI : 165.82 (-2.17%)
PODD : 268.32 (+1.10%)
IRTC : 104.49 (+0.14%)
DXCM : 73.80 (-1.74%)
Got $200? 2 Healthcare Stocks to Buy and Hold Forever

Healthcare is considered a defensive industry, since good medical care is needed regardless of economic or market conditions. Therefore many companies in this sector are somewhat insulated from the impact...

$SPX : 5,667.56 (+0.08%)
DXCM : 73.80 (-1.74%)
BMY : 61.07 (+1.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of...

See More

Key Turning Points

3rd Resistance Point 76.37
2nd Resistance Point 75.43
1st Resistance Point 74.61
Last Price 73.80
1st Support Level 72.86
2nd Support Level 71.92
3rd Support Level 71.10

See More

52-Week High 142.00
Fibonacci 61.8% 111.57
Fibonacci 50% 102.17
Fibonacci 38.2% 92.77
Last Price 73.80
52-Week Low 62.34

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar